Immunotherapy of murine leukemia. XI. Di
β
Carolyn L. Pettey; Jeffrey J. Collins
π
Article
π
1984
π
John Wiley and Sons
π
French
β 868 KB
## Abstract It has previously been shown that DBA/2 mice protected against the development of Friend leukemia virus (FLV)^4^βinduced disease by the passive administration of heterologous antisera directed against disrupted virions or the major viral envelope glycoprotein (gp71) fail to undergo the